Home » Pfizer’s Wyeth Ordered to Face Class-Action Over Pristiq
Pfizer’s Wyeth Ordered to Face Class-Action Over Pristiq
A federal judge has granted class-action status to former Wyeth shareholders who accused the company, now part of Pfizer, of misleading them about risks associated with the antidepressant Pristiq.
Reuters
Reuters
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May